CTLA4 and colorectal cancer: M6A-modified circQSOX1 promoted colorectal cancer tumorigenesis by promoting PGAM1 expression by sponging miR-326 and miR-330-5p and further facilitated colorectal immune escape by activating glycolysis and inactivating anti-CTLA-4 therapeutic response [39].